Boston Scientific develops and manufactures medical devices for use in minimally invasive procedures across cardiology, endoscopy, neuromodulation, and other specialties. Its products include stents, pacemakers, catheters, and endoscopic tools that help physicians diagnose and treat patients. The company markets these technologies to hospitals and healthcare providers around the world.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 4,663 | — | 674 | — |
| Q2 2025 | 5,061 | — | 797 | — |
| Q3 2025 | 5,065 | — | 755 | — |
| Q4 2025 | 5,286 | — | 672 | — |
| Q1 2026 | 5,203 | 11.6% | 1,341 | 99% |
All markets — KeepWinning global stock screener
Other companies on NYSE: TC Energy Corporation (TRP), United Rentals, Inc. (URI), MetLife, Inc. (MET), TransDigm Group Incorporated (TDG), Targa Resources Corp. (TRGP), Takeda Pharmaceutical Company Limited (TAK)